Excess placental production of soluble fms-like tyrosine kinase (sFLT1), an antagonist of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) has been shown to be associated with decreased circulating levels of VEGF and PlGF in preeclampsia patients3. This evidence concerns the gene PGF and preeclampsia.